Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Science Signaling|February 18, 2016
ONC201: Stressing tumors to deathYoshimi Endo Greer, Stanley LipkowitzCells|December 11, 2022
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer TherapyManjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, et al.Cancers|April 13, 2023
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast CancerRohan Wedam, Yoshimi Endo Greer, David J Wisniewski, et al.Breast Cancer Research : BCR|February 20, 2019
MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancerYoshimi Endo Greer, Samuel F Gilbert, Brunilde Gril, et al.The Journal of Cell Biology|March 23, 2011
Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowthYoshimi Endo Greer, Jeffrey S RubinCancer Gene Therapy|February 29, 2024
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancerKei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, et al.Oncogene|November 25, 2025
EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibitionDavid J Wisniewski, Donna Voeller, Yonit A Addissie, et al.Plos One|January 27, 2017
Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1Yoshimi Endo Greer, Bo Gao, Yingzi Yang, et al.Nature Reviews. Cancer|August 25, 2011
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisStanley Lipkowitz, Allan M WeissmanCell Death & Disease|April 25, 2025
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancerKei Kudo, Yoshimi Endo Greer, Daniel R Crooks, et al.Pageof 10